Abstract
Objectives
The gastrointestinal microbiota is considered important in inflammatory bowel disease (IBD) pathogenesis. Discoveries from established disease cohorts report reduced bacterial diversity, changes in bacterial composition, and a protective role for Faecalibacterium prausnitzii in Crohn's disease (CD). The majority of studies to date are however potentially confounded by the effect of treatment and a reliance on established rather than de-novo disease.Methods
Microbial changes at diagnosis were examined by biopsying the colonic mucosa of 37 children: 25 with newly presenting, untreated IBD with active colitis (13 CD and 12 ulcerative colitis (UC)), and 12 pediatric controls with a macroscopically and microscopically normal colon. We utilized a dual-methodology approach with pyrosequencing (threshold >10,000 reads) and confirmatory real-time PCR (RT-PCR).Results
Threshold pyrosequencing output was obtained on 34 subjects (11 CD, 11 UC, 12 controls). No significant changes were noted at phylum level among the Bacteroidetes, Firmicutes, or Proteobacteria. A significant reduction in bacterial α-diversity was noted in CD vs. controls by three methods (Shannon, Simpson, and phylogenetic diversity) but not in UC vs. controls. An increase in Faecalibacterium was observed in CD compared with controls by pyrosequencing (mean 16.7% vs. 9.1% of reads, P=0.02) and replicated by specific F. prausnitzii RT-PCR (36.0% vs. 19.0% of total bacteria, P=0.02). No disease-specific clustering was evident on principal components analysis.Conclusions
Our results offer a comprehensive examination of the IBD mucosal microbiota at diagnosis, unaffected by therapeutic confounders or changes over time. Our results challenge the current model of a protective role for F. prausnitzii in CD, suggesting a more dynamic role for this organism than previously described.Full text links
Read article at publisher's site: https://doi.org/10.1038/ajg.2012.335
Read article for free, from open access legal sources, via Unpaywall:
https://journals.lww.com/ajg/Fulltext/2012/12000/Microbiota_ofDe_NovoPediatric_IBD_.26.aspx
References
Articles referenced by this article (48)
Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends.
Inflamm Bowel Dis, (1):423-439 2011
MED: 20564651
Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.
Gastroenterology, (1):46-54.e42; quiz e30 2011
MED: 22001864
Rising incidence of pediatric inflammatory bowel disease in Scotland.
Inflamm Bowel Dis, (6):999-1005 2011
MED: 21688352
Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry.
Nat Immunol, (1):55-62 2009
MED: 19898471
NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation.
Nat Med, (1):90-97 2009
MED: 19966812
The gut microbiota shapes intestinal immune responses during health and disease.
Nat Rev Immunol, (5):313-323 2009
MED: 19343057
Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease.
Gut, (5):685-693 2004
MED: 15082587
Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease.
Gut, (12):1760-1767 2006
MED: 16648155
Show 10 more references (10 of 48)
Citations & impact
Impact metrics
Article citations
Optimised human stool sample collection for multi-omic microbiota analysis.
Sci Rep, 14(1):16816, 22 Jul 2024
Cited by: 0 articles | PMID: 39039185 | PMCID: PMC11263584
Familial clustering of dysbiotic oral and fecal microbiomes in juvenile dermatomyositis.
Sci Rep, 14(1):16158, 12 Jul 2024
Cited by: 0 articles | PMID: 38997299 | PMCID: PMC11245510
Persistent dysbiosis of duodenal microbiota in patients with controlled pediatric Crohn's disease after resolution of inflammation.
Sci Rep, 14(1):12668, 03 Jun 2024
Cited by: 0 articles | PMID: 38830904 | PMCID: PMC11148174
Current Knowledge on the Preparation and Benefits of Cruciferous Vegetables as Relates to In Vitro, In Vivo, and Clinical Models of Inflammatory Bowel Disease.
Curr Dev Nutr, 8(5):102160, 17 Apr 2024
Cited by: 0 articles | PMID: 38779039 | PMCID: PMC11108850
Review Free full text in Europe PMC
Intestinal Fibrogenesis in Inflammatory Bowel Diseases: Exploring the Potential Role of Gut Microbiota Metabolites as Modulators.
Pharmaceuticals (Basel), 17(4):490, 11 Apr 2024
Cited by: 0 articles | PMID: 38675450 | PMCID: PMC11053610
Review Free full text in Europe PMC
Go to all (171) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Terminal restriction fragment length polymorphism analysis of the gut microbiota profiles of pediatric patients with inflammatory bowel disease.
Digestion, 86(2):129-135, 27 Jul 2012
Cited by: 16 articles | PMID: 22846404
Microbiota in pediatric inflammatory bowel disease.
J Pediatr, 157(2):240-244.e1, 18 Apr 2010
Cited by: 102 articles | PMID: 20400104
Low counts of Faecalibacterium prausnitzii in colitis microbiota.
Inflamm Bowel Dis, 15(8):1183-1189, 01 Aug 2009
Cited by: 706 articles | PMID: 19235886
Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
J Pediatr Gastroenterol Nutr, 44(5):653-674, 01 May 2007
Cited by: 240 articles | PMID: 17460505
The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis.
Scand J Gastroenterol, 51(12):1407-1415, 09 Aug 2016
Cited by: 101 articles | PMID: 27687331
Review
Funding
Funders who supported this work.
Chief Scientist Office (1)
The role of non-pylori heliobacter in de-novo paediatric inflammatory bowel disease
Dr Richard Hansen
Grant ID: CAF/08/01